- Home
- BNTX vs DTE Comparison
BNTX vs DTE Comparison
Compare BNTX & DTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTX
- DTE
- Stock Information
- Founded
- BNTX 2008
- DTE 1903
- Country
- BNTX Germany
- DTE United States
- Employees
- BNTX N/A
- DTE N/A
- Industry
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- DTE Electric Utilities: Central
- Sector
- BNTX Health Care
- DTE Utilities
- Exchange
- BNTX Nasdaq
- DTE Nasdaq
- Market Cap
- BNTX 23.9B
- DTE 26.1B
- IPO Year
- BNTX 2019
- DTE N/A
- Fundamental
- Price
- BNTX $122.48
- DTE $121.79
- Analyst Decision
- BNTX Strong Buy
- DTE Buy
- Analyst Count
- BNTX 14
- DTE 16
- Target Price
- BNTX $141.60
- DTE $130.62
- AVG Volume (30 Days)
- BNTX 1.1M
- DTE 1.6M
- Earning Date
- BNTX 11-04-2024
- DTE 10-24-2024
- Dividend Yield
- BNTX N/A
- DTE 3.33%
- EPS Growth
- BNTX N/A
- DTE 21.85
- EPS
- BNTX N/A
- DTE 7.38
- Revenue
- BNTX $3,390,698,192.00
- DTE $12,415,000,000.00
- Revenue This Year
- BNTX N/A
- DTE $1.31
- Revenue Next Year
- BNTX N/A
- DTE $2.12
- P/E Ratio
- BNTX N/A
- DTE $16.59
- Revenue Growth
- BNTX N/A
- DTE N/A
- 52 Week Low
- BNTX $76.53
- DTE $102.17
- 52 Week High
- BNTX $131.49
- DTE $131.67
- Technical
- Relative Strength Index (RSI)
- BNTX 61.56
- DTE 44.85
- Support Level
- BNTX $112.96
- DTE $121.77
- Resistance Level
- BNTX $121.80
- DTE $127.53
- Average True Range (ATR)
- BNTX 4.86
- DTE 1.52
- MACD
- BNTX 1.13
- DTE 0.02
- Stochastic Oscillator
- BNTX 97.68
- DTE 32.76
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.
About DTE DTE Energy Company
DTE Energy owns two regulated utilities in Michigan that contribute 90% of earnings. DTE Electric serves approximately 2.3 million customers in southeastern Michigan, including Detroit. DTE Gas serves 1.3 million customers throughout the state. In addition, DTE has nonutility businesses and investments including energy marketing and trading, renewable natural gas facilities, and on-site industrial energy projects.